Dark

Check out our Level2View

PRPO
Precipio, Inc. Common Stock
stock NASDAQ

At Close

Feb 27, 2026

24.08USD-0.885%(-0.22)18,512

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-24.30)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Nov 18, 2021

10:02AM EST Precipio Reports New York State Approved Co.'s HemeScreen For Physician-Owned Labs Clinical Use Benzinga

10:00AM EST Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from New York States Department of Health (NY DOH). Hemescreen can now be used by New York based physician-owned laboratories (POLs) who apply to run HemeScreen in their lab as a laboratory-developed test (LDT). GlobeNewswire Inc

Nov 15, 2021

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 3, 2021

08:00AM EDT 89bio Announces Appointment of Kathy LaPorte to its Board of Directors GlobeNewswire Inc

Nov 1, 2021

05:00PM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM ET. The call will include updates on the companys current core businesses. GlobeNewswire Inc

Aug 27, 2021

06:44AM EDT The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.17 A.M. EDT). RTTNews

Aug 26, 2021

10:01AM EDT Precipio Reports Partnership With American Oncology Network To Adopt Co.'s HemeScreen Technology, No Terms Disclosed Benzinga

10:00AM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth community oncology provider, announces the signing of an agreement under which AON will adopt Precipios HemeScreen technology and begin running HemeScreen in its central laboratory located in Fort Myers, Florida. GlobeNewswire Inc

Aug 20, 2021

05:00PM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to Thursday, August 26th at 5:00 PM ET due to a schedule conflict. GlobeNewswire Inc

Aug 18, 2021

05:57AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT). RTTNews

Aug 13, 2021

10:48AM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET. The call will include discussions on all of the companys core businesses. GlobeNewswire Inc

Jul 28, 2021

10:02AM EDT UPDATE: Precipio Sees Continued Sales Growth For Its HemeScreen POL Unit, Sees 'profits that should lead to material reductions in our cash-burn' Benzinga

10:01AM EDT UPDATE: Precipio Sees Q2 Case Volume For Its Pathology Services Unit Up 60% Year Over Year Benzinga

10:01AM EDT Precipio Says Prelim. Unaudited Q2 Sales Showed 'continued substantial YoY and quarterly growth' Benzinga

10:00AM EDT Specialty diagnostics Company Precipio, Inc.(NASDAQ: PRPO), announces preliminary unaudited revenues for Q2-2021 demonstrating continued substantial YoY and quarterly growth. GlobeNewswire Inc

Jun 15, 2021

11:03AM EDT Precipio Terminates Equity Line With Lincoln Park Capital Benzinga

11:00AM EDT Specialty diagnostics Company Precipio, Inc.(NASDAQ: PRPO), announces that as part of managements review of its current financing arrangements, it has terminated the equity line financing structure it had in place with Lincoln Park Capital. GlobeNewswire Inc

Jun 8, 2021

10:30AM EDT Precipio Highlights Launch Of Its HomeScreen Anemia Panel Benzinga

10:30AM EDT Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes GlobeNewswire Inc

May 20, 2021

10:13AM EDT Mid-Morning Market Update: Markets Rise; Hormel Foods Beats Q2 Views Benzinga

08:27AM EDT The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks Benzinga

May 14, 2021

04:30PM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q1-2021 corporate update call on Thursday, May 20th at 5:00 PM ET. The call will include updates on all of the companys current core businesses. GlobeNewswire Inc

May 10, 2021

02:40PM EDT Mid-Afternoon Market Update: Dow Surges 125 Points; Trade Desk Shares Plunge Benzinga

12:15PM EDT Mid-Day Market Update: Nasdaq Drops 200 Points; Soliton Shares Spike Higher Benzinga

10:33AM EDT Precipio Says Launches New HemeScreen Panel For AML Benzinga

10:30AM EDT Specialty diagnostics company Precipio, Inc.(NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML) HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia. When physicians are armed with the genetic character of the disease, they can rapidly and precisely select the most effective targeted therapeutic. GlobeNewswire Inc

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

May 4, 2021

11:57AM EDT Why Precipio's Stock Is Moving Higher Today Benzinga

10:25AM EDT Mid-Morning Market Update: Markets Open Lower; Pfizer Raises FY21 Outlook Benzinga

09:56AM EDT Precipio, Inc. (PRPO) shares are spiking on Tuesday morning trade after the specialty diagnostics company launched its COVID-19 rapid antibody test for both IgG & IgM antibodies, on Amazon.com's business platform. The company noted that the antibody test has received emergency use authorization by the FDA for point-of-care. RTTNews

May 3, 2021

09:30AM EDT Precipio Highlights Successful Launch Of COVID-19 Rapid Antibody Test On Amazon.com's Business Platform Benzinga

09:30AM EDT Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform GlobeNewswire Inc

Apr 26, 2021

11:03AM EDT Precipio Says Contracted Annualized Revenues From Signed Customers For HemeScreen POL Exceeded $750K Benzinga

11:00AM EDT Specialty diagnostics company Precipio, Inc.(NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers for its HemeScreen POL (Physician Office Laboratory) testing system exceed $750,000 and for the reasons set forth below, by Q4-2021 this cohort is expected to result in reported quarterly revenues with an annualized run rate of $1,000,000. GlobeNewswire Inc

Apr 5, 2021

09:06AM EDT Precipio Enters Into At-The-Market Financing Arrangement Of Up To $20M Benzinga

09:00AM EDT Precipio Enters Into an At-The -Market (ATM) Financing Arrangement GlobeNewswire Inc

Mar 31, 2021

07:41AM EDT The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO Benzinga

Mar 30, 2021

09:01AM EDT Precipio Reports FY20 Sales $6.1M vs $3M In FY19; Q4 Gross Profit $500K, Up 27% Quarter Over Quarter Benzinga

09:00AM EDT FY-2020 FY-2019 Increase (%) Increase ($)Revenues $6.1M $3.1M ? 95% ? $3.0MGross profit $1.2M $0.3M ? 425% ? $0.9M Q4-2020 Q3-2020 Increase (%) Increase ($)Revenues $1.9M $1.6M ? 19% ? $0.3MGross profit $0.5M $0.4M ? 27% ? $0.1M GlobeNewswire Inc

Mar 27, 2021

01:01PM EDT The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week Benzinga

Mar 18, 2021

04:30PM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q4-2020 and year end corporate update call on Wednesday, March 31st at 5:00 PM ET. The call will include updates on all of the companys current core businesses. GlobeNewswire Inc

Mar 3, 2021

01:00PM EST Mr. Ron Andrews joins Precipios Board of Directors GlobeNewswire Inc

11:00AM EST Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) announces the appointment of Mr. Richard Sandberg as Chairman of the Board of Directors. Dr. Douglas Fisher will step down as Chairman and maintain his role as a Director on the companys board. GlobeNewswire Inc

Jan 28, 2021

09:33AM EST Precipio Launches COVID-19 Antibody Testing At Point-Of-Care Benzinga

09:30AM EST Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA by Nirmidas Biotech, Inc., the developer and manufacturer of the COVID-19 antibody test, Precipio has begun to roll out these tests to the market. GlobeNewswire Inc

Jan 20, 2021

10:01AM EST Precipio Reports Signed Deal With 2 Of Largest Oncology Practices In US, West Cancer Center, New York Cancer & Blood Specialists, No Terms Disclosed Benzinga

10:00AM EST Precipio Signs HemeScreen Deals with Two Leading GlobeNewswire Inc

Dec 10, 2020

10:15AM EST Precipio Signs Sales & Marketing Agreement For HemeScreen With Major Oncology Distributor Benzinga

10:15AM EST Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO) has entered into an agreement with a major US-based oncology distributor to offer Precipios HemeScreen POL (Physician Office Lab) program to its independent community oncology practices nationwide. At this time, the company had requested to remain unnamed in this press release. GlobeNewswire Inc

Nov 19, 2020

08:17AM EST The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway Benzinga

04:24AM EST Earnings Scheduled For November 19, 2020 Benzinga

Nov 11, 2020

09:00AM EST Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November 19th at 5:00 PM ET. The call will include updates on the companys current core businesses, as well as an update on the companys COVID-19 testing initiative. GlobeNewswire Inc

Oct 6, 2020

10:00AM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase testing for its new IV-cell cytogenetics culturing media. GlobeNewswire Inc

Sep 22, 2020

10:32AM EDT Precipio Launches Proprietary HemeScreen AML Molecular Panel Benzinga

10:30AM EDT Precipio Launches its Proprietary HemeScreen AML GlobeNewswire Inc

Sep 10, 2020

10:20AM EDT Mid-Morning Market Update: Markets Open Higher; RH Tops Q2 Expectations Benzinga

Sep 9, 2020

01:48PM EDT Precipio Shares Move Higher; Co Announced On Sept. 4 Would Host Shareholder Call To Address Company's COVID-19 Strategy, Call Set To Take Place Today At 5 p.m. EDT Benzinga

Sep 4, 2020

09:03AM EDT Precipio Announces Shareholder Call To Discuss Its COVID-19 Progress And Future Plans Sept. 9 At 5:00 p.m. EST Benzinga

09:00AM EDT Precipio Announces a Shareholder Call to Discuss its COVID-19 GlobeNewswire Inc

Aug 20, 2020

01:00PM EDT Precipio & ADS Biotec Sign Global Distribution Agreement for GlobeNewswire Inc

Aug 13, 2020

03:13PM EDT Precipio Q2 EPS $(0.20), Inline, Sales $1.65M Beat $900.00K Estimate Benzinga

Aug 7, 2020

09:00AM EDT Specialty cancer diagnostics companyPrecipio, Inc.(NASDAQ: PRPO), will be hosting its Q2-2020 corporate update call on Monday, August 17th at 5:00 PM ET. The call will include updates on the companys current core businesses, as well as an update on the companys COVID-19 testing initiative. GlobeNewswire Inc

Aug 4, 2020

11:39AM EDT Precipio Shares Resume Trading To The Downside, Shares Up 31% Benzinga

11:34AM EDT Precipio Shares Halted Again, On Volatility, To The Downside; Shares Up 31% For The Session Benzinga

11:29AM EDT Precipio Shares Resume Trading, Move Down; Shares Up 48% For The Session Benzinga

11:24AM EDT Precipio Halted On Volatility Again; Shares Up 53% Benzinga

11:22AM EDT Precipio Shares Resume Trading, Previously Halted On Volatility; Shares Up 46% Benzinga

10:46AM EDT Precipio Press Release Highlights Launch Of Coronavirus Antibody Test In Its CLIA Lab Benzinga

10:45AM EDT Precipio Launches Covid-19 Antibody Test in its CLIA laboratory GlobeNewswire Inc

Jul 31, 2020

02:36PM EDT Mid-Afternoon Market Update: Dow Falls 175 Points; Pinterest Shares Climb Following Strong Results Benzinga

12:40PM EDT Mid-Day Market Update: Gold Surges 2.5%; Tiziana Life Sciences Shares Spike Higher Benzinga

10:13AM EDT Mid-Morning Market Update: Markets Mixed; Apple Beats Q3 Expectations Benzinga

Jul 30, 2020

01:12PM EDT Precipio Shares Resume Trading; Shares Up 250% Benzinga

12:56PM EDT Precipio Halted, Again, On Volatility Benzinga

12:52PM EDT Precipio Shares Resume Trading, Move Lower, Up 380% Benzinga

12:49PM EDT Precipio Shares Halted On Volatility; Shares Up 475% Benzinga

12:46PM EDT Precipio Shares Resume Trading; Above $6 Benzinga

11:51AM EDT Precipio Shares Halted; Hearing Shares Indicated At $5 Benzinga

10:17AM EDT Precipio Shares Spike Higher, Halted On Volatility, After Co. Announces Commerical Launch Of Coronavirus Antibody Test; Shares Up 29% For The Session Benzinga

10:16AM EDT Precipio Announces Commercial Launch of Coronavirus Antibody Test Benzinga

10:15AM EDT Precipio Announces Commercial Launch of COVID-19 Antibody Test GlobeNewswire Inc

Jul 22, 2020

10:15AM EDT Precipio Announces Q2-2020 Unaudited Pathology Services Revenue GlobeNewswire Inc

Share